The role of protein lactylation: A kaleidoscopic post-translational modification in cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lysine lactylation, a key epigenetic modification, impacts gene expression and protein function. Targeting this process shows promise for novel cancer therapies by influencing tumor growth and metastasis.
Area Of Science
- Biochemistry
- Molecular Biology
- Cancer Biology
Background
- Lysine lactylation is a newly identified post-translational modification.
- It affects both histone and non-histone proteins, influencing gene transcription and cellular functions.
- Two distinct sources, L-lactyl-CoA and S-D-lactylglutathione, contribute to lactylation via enzymatic and non-enzymatic pathways.
Purpose Of The Study
- To review the current understanding of lysine lactylation.
- To highlight its role in epigenetics and cancer biology.
- To explore its potential as a therapeutic target in oncology.
Main Methods
- Literature review of recent findings on lysine lactylation.
- Analysis of proposed enzymatic and non-enzymatic mechanisms.
- Discussion of the role of acetyltransferases and deacetylases.
Main Results
- Lysine lactylation is involved in transcriptional activation and protein regulation.
- The modification influences key cancer-related pathways, affecting malignancy and metastasis.
- While specific mediators are under investigation, acetyltransferases and deacetylases are implicated.
Conclusions
- Lysine lactylation is a significant epigenetic regulator with implications for cancer.
- Understanding its mechanisms is crucial for developing targeted cancer treatments.
- Targeting lysine lactylation presents a promising avenue for future cancer therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...